CEPI is providing US$4.5 million to non-profit Fondazione Biotecnopolo di Siena (FBS) for proof-of-concept research that will ...

Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...

Historical Prices for Direxion Daily S&P Biotech Bull 3X Shares Sustainability Rating Indices Commodities Currencies Stocks ...

A new part of an ocean plant cell has been discovered that might revolutionize farming one day. The structure can take ...

The 10 most innovative biotech companies of 2025 are leveraging ... across its single-cell and spatial platforms, including GEM-X, an innovative microfluidic chip design that allows for ...

Holding Bitcoin could help biotech firms survive the long period of time it takes to bring products to market, says Atai Life ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ...

as biotech emerges as a new front in the escalating US-China tech war. Akeso's new immunotherapy drug targeting non-small cell lung cancer, called ivonescimab, allowed half of its patients to go ...

Roche, which put billions on the line a year ago across several ADC pacts, kicked off 2025 by returning to Innovent Biologics ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Exelixis, Inc.

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

Alvotech acquires Xbrane’s R&D operations and the biosimilar candidate XB003. Xbrane retains some pre-clinical development programs, that it intends to commercialize, and will continue operating as a ...